Add-on Tiotropium in Chinese Patients With Moderate Asthma: A Pooled Subgroup Analysis of MezzoTinA-Asthma 1 and 2

PURPOSE: Asthma affects approximately 30 million patients in China; however, tiotropium data for Chinese patients is limited. This study aimed to assess the efficacy and safety of tiotropium in Chinese patients with moderate symptomatic asthma. METHODS: A post hoc subgroup analysis was conducted on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jiangtao, Wan, Huanying, Kang, Jian, Ma, Qianli, Chen, Ping, Jin, Meiling, Wang, Haoyan, Liu, Shuang, Hao, Qinglin, Lin, Yong, Su, Lin, Hu, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557774/
https://www.ncbi.nlm.nih.gov/pubmed/31172720
http://dx.doi.org/10.4168/aair.2019.11.4.519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557774/
https://www.ncbi.nlm.nih.gov/pubmed/31172720
http://dx.doi.org/10.4168/aair.2019.11.4.519

Ejemplares similares